| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Excitatory Amino Acid Transporter 2 | 20 | 2020 | 89 | 6.150 |
Why?
|
| Oligodendroglia | 36 | 2024 | 535 | 4.900 |
Why?
|
| Zinc | 10 | 2024 | 690 | 2.620 |
Why?
|
| Glutamic Acid | 25 | 2021 | 1166 | 2.510 |
Why?
|
| Neurons | 53 | 2023 | 9416 | 2.330 |
Why?
|
| Astrocytes | 30 | 2023 | 1335 | 2.070 |
Why?
|
| Periapical Periodontitis | 8 | 2014 | 28 | 1.830 |
Why?
|
| Root Canal Therapy | 17 | 2014 | 66 | 1.600 |
Why?
|
| Cerebral Cortex | 43 | 2019 | 5755 | 1.430 |
Why?
|
| Arachidonate 12-Lipoxygenase | 6 | 2009 | 82 | 1.390 |
Why?
|
| Adenosine | 13 | 2007 | 833 | 1.380 |
Why?
|
| Leukomalacia, Periventricular | 8 | 2014 | 184 | 1.340 |
Why?
|
| Periapical Diseases | 4 | 2015 | 21 | 1.320 |
Why?
|
| Peroxynitrous Acid | 6 | 2008 | 42 | 1.300 |
Why?
|
| Homeostasis | 9 | 2024 | 3305 | 1.130 |
Why?
|
| Prosencephalon | 8 | 2009 | 305 | 1.120 |
Why?
|
| Radicular Cyst | 4 | 2015 | 12 | 1.110 |
Why?
|
| Rats | 96 | 2015 | 23695 | 1.040 |
Why?
|
| Dental Pulp Necrosis | 6 | 2015 | 22 | 1.030 |
Why?
|
| Huntington Disease | 5 | 2021 | 1140 | 1.000 |
Why?
|
| Calcium Signaling | 3 | 2020 | 731 | 0.980 |
Why?
|
| Rats, Sprague-Dawley | 53 | 2013 | 8157 | 0.940 |
Why?
|
| Presynaptic Terminals | 6 | 2019 | 301 | 0.920 |
Why?
|
| Cells, Cultured | 63 | 2024 | 18968 | 0.860 |
Why?
|
| Corpus Striatum | 5 | 2020 | 1233 | 0.850 |
Why?
|
| Dental Pulp Diseases | 4 | 2011 | 12 | 0.840 |
Why?
|
| Dopamine | 4 | 2020 | 1583 | 0.840 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 15 | 2007 | 893 | 0.820 |
Why?
|
| Synaptosomes | 8 | 2019 | 115 | 0.780 |
Why?
|
| Cell Death | 19 | 2019 | 1670 | 0.770 |
Why?
|
| Oxidative Stress | 16 | 2023 | 3107 | 0.770 |
Why?
|
| Molsidomine | 3 | 2004 | 22 | 0.710 |
Why?
|
| Adenosine Kinase | 3 | 2006 | 13 | 0.690 |
Why?
|
| Extracellular Space | 11 | 2004 | 565 | 0.680 |
Why?
|
| Animals | 136 | 2024 | 167940 | 0.660 |
Why?
|
| Coronary Sinus | 1 | 2020 | 84 | 0.660 |
Why?
|
| Cyclic GMP | 6 | 2006 | 395 | 0.650 |
Why?
|
| Nitric Oxide | 8 | 2006 | 2141 | 0.630 |
Why?
|
| Cation Transport Proteins | 2 | 2020 | 325 | 0.600 |
Why?
|
| Dental Pulp | 9 | 2012 | 84 | 0.590 |
Why?
|
| Cyclic AMP | 9 | 2006 | 1455 | 0.580 |
Why?
|
| Cell Differentiation | 13 | 2024 | 11480 | 0.570 |
Why?
|
| Hippocampus | 10 | 2020 | 3737 | 0.570 |
Why?
|
| Glutathione | 9 | 2004 | 582 | 0.570 |
Why?
|
| Hypoxia-Ischemia, Brain | 7 | 2014 | 352 | 0.570 |
Why?
|
| Synaptic Transmission | 4 | 2015 | 1169 | 0.560 |
Why?
|
| Amphetamine | 1 | 2018 | 224 | 0.560 |
Why?
|
| Infant, Premature, Diseases | 2 | 2014 | 708 | 0.550 |
Why?
|
| Vesicular Glutamate Transport Proteins | 1 | 2016 | 4 | 0.550 |
Why?
|
| Nerve Fibers, Myelinated | 6 | 2009 | 952 | 0.530 |
Why?
|
| N-Methylaspartate | 12 | 2004 | 231 | 0.530 |
Why?
|
| Amino Acid Transport System X-AG | 4 | 2019 | 39 | 0.530 |
Why?
|
| Receptors, Glutamate | 6 | 2014 | 229 | 0.530 |
Why?
|
| Incisor | 3 | 2015 | 174 | 0.520 |
Why?
|
| Cementoma | 1 | 2015 | 6 | 0.520 |
Why?
|
| Carrier Proteins | 5 | 2020 | 4938 | 0.510 |
Why?
|
| Locomotion | 1 | 2018 | 388 | 0.500 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 462 | 0.490 |
Why?
|
| Myelin Sheath | 4 | 2014 | 651 | 0.490 |
Why?
|
| Neurotoxins | 7 | 1997 | 240 | 0.490 |
Why?
|
| Apoptosis | 15 | 2009 | 9497 | 0.480 |
Why?
|
| Mandibular Neoplasms | 1 | 2015 | 130 | 0.470 |
Why?
|
| Heart Conduction System | 1 | 2020 | 1016 | 0.470 |
Why?
|
| Excitatory Amino Acid Agonists | 6 | 2004 | 143 | 0.460 |
Why?
|
| Glutamates | 8 | 1994 | 391 | 0.460 |
Why?
|
| Gene Deletion | 2 | 2020 | 2668 | 0.450 |
Why?
|
| Root Canal Filling Materials | 7 | 2015 | 29 | 0.450 |
Why?
|
| Heart Atria | 1 | 2020 | 1344 | 0.450 |
Why?
|
| Mice, Knockout | 14 | 2020 | 14396 | 0.430 |
Why?
|
| Phosphorylation | 8 | 2020 | 8314 | 0.430 |
Why?
|
| Periapical Abscess | 5 | 2014 | 17 | 0.420 |
Why?
|
| Myocytes, Cardiac | 2 | 2020 | 1656 | 0.420 |
Why?
|
| Excitatory Amino Acid Transporter 3 | 2 | 2009 | 32 | 0.410 |
Why?
|
| Neuroprotective Agents | 8 | 2009 | 961 | 0.410 |
Why?
|
| Carticaine | 2 | 2012 | 3 | 0.400 |
Why?
|
| Central Nervous System Stimulants | 1 | 2020 | 1169 | 0.400 |
Why?
|
| Microglia | 5 | 2011 | 1348 | 0.390 |
Why?
|
| Animals, Newborn | 13 | 2011 | 2671 | 0.390 |
Why?
|
| Dihydroxyphenylalanine | 6 | 1995 | 73 | 0.380 |
Why?
|
| Kainic Acid | 5 | 2009 | 199 | 0.380 |
Why?
|
| Patch-Clamp Techniques | 8 | 2015 | 932 | 0.380 |
Why?
|
| Dental Pulp Test | 2 | 2009 | 5 | 0.380 |
Why?
|
| Cell Survival | 16 | 2009 | 5796 | 0.370 |
Why?
|
| Synapses | 7 | 2021 | 1753 | 0.370 |
Why?
|
| Leukoencephalopathies | 1 | 2014 | 249 | 0.370 |
Why?
|
| Nuclear Proteins | 4 | 2014 | 5793 | 0.370 |
Why?
|
| Quinolones | 5 | 2002 | 377 | 0.360 |
Why?
|
| Amyloid | 2 | 2013 | 843 | 0.360 |
Why?
|
| Calcium Channels | 2 | 2012 | 619 | 0.360 |
Why?
|
| Muscle Development | 1 | 2012 | 261 | 0.350 |
Why?
|
| Catalase | 5 | 2004 | 216 | 0.350 |
Why?
|
| Brain | 19 | 2020 | 26912 | 0.350 |
Why?
|
| Apexification | 4 | 2015 | 16 | 0.350 |
Why?
|
| Periodontal Ligament | 5 | 2010 | 117 | 0.350 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2015 | 470 | 0.350 |
Why?
|
| Lidocaine | 4 | 2007 | 538 | 0.350 |
Why?
|
| Bungarotoxins | 3 | 1995 | 46 | 0.340 |
Why?
|
| Mitochondria | 8 | 2020 | 3598 | 0.330 |
Why?
|
| Synaptic Potentials | 1 | 2009 | 44 | 0.330 |
Why?
|
| Intracellular Space | 3 | 2005 | 197 | 0.330 |
Why?
|
| Neuroglia | 3 | 2014 | 944 | 0.330 |
Why?
|
| Encephalitis | 2 | 2014 | 436 | 0.320 |
Why?
|
| Estradiol | 4 | 2014 | 1932 | 0.320 |
Why?
|
| Hyperoxia | 2 | 2008 | 250 | 0.320 |
Why?
|
| Guided Tissue Regeneration, Periodontal | 1 | 2010 | 152 | 0.320 |
Why?
|
| Quinoxalines | 8 | 2009 | 297 | 0.310 |
Why?
|
| Ventral Tegmental Area | 2 | 2020 | 134 | 0.310 |
Why?
|
| Pulpitis | 5 | 2012 | 29 | 0.310 |
Why?
|
| Purinones | 2 | 2004 | 13 | 0.310 |
Why?
|
| Dental Care for Chronically Ill | 1 | 2008 | 32 | 0.310 |
Why?
|
| Aspartic Acid | 6 | 2020 | 576 | 0.310 |
Why?
|
| PDZ Domains | 1 | 2008 | 23 | 0.310 |
Why?
|
| Vitamin K 2 | 2 | 2009 | 47 | 0.310 |
Why?
|
| Phosphodiesterase Inhibitors | 3 | 2004 | 214 | 0.300 |
Why?
|
| Metallothionein | 2 | 2024 | 61 | 0.300 |
Why?
|
| Endodontics | 1 | 2007 | 20 | 0.300 |
Why?
|
| Adenosine Triphosphate | 5 | 2004 | 1995 | 0.300 |
Why?
|
| Granuloma | 1 | 2010 | 328 | 0.290 |
Why?
|
| Protein Kinase C | 2 | 2007 | 1201 | 0.290 |
Why?
|
| Enzyme Inhibitors | 5 | 2007 | 3726 | 0.290 |
Why?
|
| Arachidonic Acid | 2 | 2009 | 434 | 0.290 |
Why?
|
| NFATC Transcription Factors | 3 | 2006 | 381 | 0.290 |
Why?
|
| Membrane Glycoproteins | 4 | 2012 | 3731 | 0.280 |
Why?
|
| RNA, Messenger | 10 | 2014 | 12762 | 0.280 |
Why?
|
| Epilepsy | 3 | 2015 | 3267 | 0.280 |
Why?
|
| Episode of Care | 1 | 2007 | 127 | 0.280 |
Why?
|
| Superoxide Dismutase | 3 | 2004 | 594 | 0.280 |
Why?
|
| Vitamin K | 1 | 2009 | 321 | 0.280 |
Why?
|
| Nucleus Accumbens | 2 | 2020 | 365 | 0.280 |
Why?
|
| Alzheimer Disease | 7 | 2021 | 8551 | 0.270 |
Why?
|
| Regeneration | 4 | 2014 | 1506 | 0.270 |
Why?
|
| Enzyme Activation | 8 | 2009 | 3604 | 0.260 |
Why?
|
| Optic Nerve Injuries | 2 | 2017 | 146 | 0.260 |
Why?
|
| Mice | 29 | 2024 | 81216 | 0.260 |
Why?
|
| Oxazoles | 1 | 2007 | 199 | 0.260 |
Why?
|
| Oximetry | 1 | 2009 | 461 | 0.260 |
Why?
|
| Ion Channel Gating | 4 | 2020 | 436 | 0.260 |
Why?
|
| Up-Regulation | 5 | 2008 | 4127 | 0.260 |
Why?
|
| Disinfection | 1 | 2007 | 209 | 0.250 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2007 | 414 | 0.250 |
Why?
|
| Brain Injuries | 3 | 2013 | 2044 | 0.250 |
Why?
|
| Anesthetics, Local | 3 | 2012 | 1001 | 0.250 |
Why?
|
| Flavoproteins | 1 | 2004 | 40 | 0.240 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 4409 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 17 | 2006 | 10829 | 0.240 |
Why?
|
| Stem Cells | 6 | 2011 | 3525 | 0.240 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2012 | 688 | 0.230 |
Why?
|
| Myoblasts | 1 | 2005 | 235 | 0.230 |
Why?
|
| Synapsins | 2 | 1995 | 43 | 0.230 |
Why?
|
| Ion Channels | 5 | 2004 | 1043 | 0.230 |
Why?
|
| Cerebellum | 3 | 2008 | 1495 | 0.230 |
Why?
|
| Excitatory Amino Acid Antagonists | 10 | 2009 | 448 | 0.230 |
Why?
|
| Hydrogen Peroxide | 3 | 2004 | 732 | 0.230 |
Why?
|
| Anesthesia, Dental | 4 | 2008 | 64 | 0.230 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 4370 | 0.230 |
Why?
|
| Sodium | 6 | 2015 | 1601 | 0.230 |
Why?
|
| Ferredoxins | 1 | 2023 | 9 | 0.230 |
Why?
|
| COS Cells | 3 | 2015 | 1129 | 0.230 |
Why?
|
| Glutathione Peroxidase | 2 | 2004 | 256 | 0.220 |
Why?
|
| Dental Pulp Cavity | 4 | 2015 | 35 | 0.220 |
Why?
|
| Pons | 1 | 2004 | 239 | 0.220 |
Why?
|
| Calcium | 14 | 2012 | 5726 | 0.220 |
Why?
|
| Quinones | 2 | 2002 | 79 | 0.220 |
Why?
|
| Vitamin K 1 | 1 | 2003 | 47 | 0.220 |
Why?
|
| Nitric Oxide Synthase | 2 | 2006 | 908 | 0.220 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 616 | 0.220 |
Why?
|
| Muscle, Skeletal | 6 | 2012 | 4923 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 12 | 2020 | 22025 | 0.210 |
Why?
|
| Root Canal Preparation | 3 | 2014 | 25 | 0.210 |
Why?
|
| Dental Leakage | 2 | 2000 | 5 | 0.210 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2004 | 428 | 0.210 |
Why?
|
| Membrane Potentials | 8 | 2009 | 1095 | 0.210 |
Why?
|
| Immunohistochemistry | 11 | 2012 | 11064 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 1246 | 0.200 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2001 | 48 | 0.200 |
Why?
|
| Rats, Long-Evans | 5 | 2013 | 373 | 0.200 |
Why?
|
| O Antigens | 3 | 2009 | 196 | 0.200 |
Why?
|
| Premature Birth | 1 | 2014 | 1771 | 0.200 |
Why?
|
| Neuromuscular Junction | 1 | 2004 | 406 | 0.190 |
Why?
|
| Nerve Regeneration | 2 | 2017 | 790 | 0.190 |
Why?
|
| Free Radicals | 6 | 2004 | 238 | 0.190 |
Why?
|
| Oxygen | 3 | 2008 | 4189 | 0.190 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2009 | 3601 | 0.190 |
Why?
|
| Drug Interactions | 5 | 2008 | 1426 | 0.190 |
Why?
|
| Dental Pulp Capping | 2 | 2011 | 5 | 0.190 |
Why?
|
| Neurotransmitter Agents | 2 | 2003 | 661 | 0.190 |
Why?
|
| Fetus | 5 | 2012 | 1859 | 0.180 |
Why?
|
| Copper | 1 | 2023 | 368 | 0.180 |
Why?
|
| Shab Potassium Channels | 2 | 2013 | 20 | 0.180 |
Why?
|
| Cell Communication | 1 | 2008 | 1642 | 0.180 |
Why?
|
| Ethylene Glycols | 2 | 2013 | 190 | 0.180 |
Why?
|
| Tooth Apex | 3 | 2015 | 28 | 0.180 |
Why?
|
| Reactive Oxygen Species | 6 | 2011 | 2138 | 0.180 |
Why?
|
| Fluorescent Dyes | 2 | 2019 | 1914 | 0.180 |
Why?
|
| Resins, Synthetic | 1 | 2000 | 25 | 0.180 |
Why?
|
| Glass Ionomer Cements | 1 | 2000 | 17 | 0.180 |
Why?
|
| Phospholipases A | 4 | 1995 | 204 | 0.180 |
Why?
|
| Bioterrorism | 2 | 2016 | 144 | 0.180 |
Why?
|
| Gliosis | 2 | 2013 | 244 | 0.170 |
Why?
|
| Dicarboxylic Acids | 2 | 1998 | 77 | 0.170 |
Why?
|
| Cerebrovascular Circulation | 2 | 2020 | 2731 | 0.170 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 99 | 0.170 |
Why?
|
| Nitroso Compounds | 1 | 1999 | 71 | 0.170 |
Why?
|
| Cognition Disorders | 2 | 2013 | 3976 | 0.170 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 12968 | 0.160 |
Why?
|
| Humans | 74 | 2023 | 760261 | 0.160 |
Why?
|
| Occlusal Adjustment | 1 | 1998 | 8 | 0.160 |
Why?
|
| Fluorine Radioisotopes | 2 | 2013 | 413 | 0.160 |
Why?
|
| Toothache | 1 | 1998 | 31 | 0.160 |
Why?
|
| Embryo, Mammalian | 5 | 2008 | 1667 | 0.150 |
Why?
|
| Apicoectomy | 4 | 2010 | 23 | 0.150 |
Why?
|
| Nitric Oxide Donors | 4 | 2006 | 125 | 0.150 |
Why?
|
| Fibroblast Growth Factors | 3 | 2011 | 867 | 0.150 |
Why?
|
| Pyrrolidines | 2 | 1998 | 338 | 0.150 |
Why?
|
| Epinephrine | 7 | 2007 | 791 | 0.150 |
Why?
|
| Disease Progression | 2 | 2013 | 13505 | 0.150 |
Why?
|
| Lipopolysaccharides | 5 | 2008 | 2214 | 0.150 |
Why?
|
| Cognition | 3 | 2020 | 6948 | 0.150 |
Why?
|
| Cementogenesis | 2 | 2010 | 10 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2004 | 829 | 0.150 |
Why?
|
| Electrophysiology | 7 | 2007 | 1265 | 0.150 |
Why?
|
| Capillary Permeability | 1 | 2021 | 768 | 0.150 |
Why?
|
| Norepinephrine | 6 | 2001 | 900 | 0.150 |
Why?
|
| 2-Amino-5-phosphonovalerate | 5 | 2000 | 58 | 0.150 |
Why?
|
| Hydrazines | 4 | 2006 | 224 | 0.140 |
Why?
|
| Mutation | 5 | 2015 | 29950 | 0.140 |
Why?
|
| Avoidance Learning | 1 | 2019 | 248 | 0.140 |
Why?
|
| Adrenergic beta-Agonists | 2 | 1996 | 345 | 0.140 |
Why?
|
| Receptors, AMPA | 5 | 2006 | 323 | 0.140 |
Why?
|
| Mice, 129 Strain | 1 | 2018 | 373 | 0.140 |
Why?
|
| Ceftriaxone | 2 | 2019 | 175 | 0.140 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 1995 | 241 | 0.140 |
Why?
|
| Epithelial Cells | 3 | 2012 | 3665 | 0.140 |
Why?
|
| Epilepsy, Generalized | 1 | 2019 | 178 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 4357 | 0.140 |
Why?
|
| Infant, Newborn | 11 | 2019 | 26168 | 0.140 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 1996 | 68 | 0.140 |
Why?
|
| Coordination Complexes | 1 | 2018 | 114 | 0.130 |
Why?
|
| Dental Materials | 3 | 2011 | 112 | 0.130 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 2008 | 93 | 0.130 |
Why?
|
| Pyruvic Acid | 3 | 2013 | 195 | 0.130 |
Why?
|
| Elapid Venoms | 2 | 1992 | 41 | 0.130 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 5 | 2003 | 55 | 0.130 |
Why?
|
| Aniline Compounds | 2 | 2013 | 1068 | 0.130 |
Why?
|
| Oxidation-Reduction | 10 | 2014 | 2222 | 0.130 |
Why?
|
| Protein Isoforms | 4 | 2005 | 1697 | 0.130 |
Why?
|
| Immunoblotting | 6 | 2007 | 1649 | 0.130 |
Why?
|
| Gluconates | 1 | 2015 | 31 | 0.130 |
Why?
|
| Myokymia | 1 | 2015 | 11 | 0.130 |
Why?
|
| PQQ Cofactor | 5 | 2002 | 5 | 0.130 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2015 | 30 | 0.130 |
Why?
|
| Thionucleotides | 2 | 2006 | 112 | 0.130 |
Why?
|
| In Situ Hybridization | 3 | 2005 | 1900 | 0.130 |
Why?
|
| Glycogen | 2 | 1987 | 251 | 0.130 |
Why?
|
| Alkaline Phosphatase | 2 | 2004 | 865 | 0.130 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2000 | 563 | 0.130 |
Why?
|
| Phorbol Esters | 1 | 1995 | 108 | 0.130 |
Why?
|
| Calcium Hydroxide | 4 | 2012 | 16 | 0.120 |
Why?
|
| Kinetics | 8 | 2011 | 6378 | 0.120 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1995 | 180 | 0.120 |
Why?
|
| Periapical Tissue | 2 | 2011 | 10 | 0.120 |
Why?
|
| Cataplexy | 1 | 2015 | 61 | 0.120 |
Why?
|
| Action Potentials | 3 | 2020 | 1814 | 0.120 |
Why?
|
| Tetrodotoxin | 3 | 2009 | 246 | 0.120 |
Why?
|
| Rats, Wistar | 5 | 2008 | 1849 | 0.120 |
Why?
|
| Membrane Proteins | 3 | 2017 | 7854 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2013 | 2449 | 0.120 |
Why?
|
| Pulpectomy | 2 | 2009 | 3 | 0.120 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 503 | 0.120 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 1017 | 0.120 |
Why?
|
| Cell Line | 6 | 2014 | 15626 | 0.120 |
Why?
|
| Antigens, CD | 3 | 2008 | 4002 | 0.120 |
Why?
|
| Tissue Distribution | 4 | 2007 | 2262 | 0.120 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2014 | 37 | 0.120 |
Why?
|
| Cyclohexylamines | 1 | 2014 | 20 | 0.120 |
Why?
|
| Chelating Agents | 3 | 2017 | 384 | 0.120 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 2 | 2005 | 182 | 0.120 |
Why?
|
| Phosphatidylcholines | 2 | 1993 | 406 | 0.120 |
Why?
|
| Dental Enamel Proteins | 2 | 2004 | 39 | 0.120 |
Why?
|
| Antioxidants | 5 | 2023 | 1668 | 0.120 |
Why?
|
| Chromatography, High Pressure Liquid | 8 | 2003 | 1549 | 0.110 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2009 | 617 | 0.110 |
Why?
|
| Infant, Premature | 3 | 2014 | 2091 | 0.110 |
Why?
|
| Hypoxia, Brain | 1 | 1994 | 138 | 0.110 |
Why?
|
| Isocitrates | 1 | 2013 | 23 | 0.110 |
Why?
|
| Phenylenediamines | 1 | 2014 | 86 | 0.110 |
Why?
|
| Wound Healing | 4 | 2011 | 2786 | 0.110 |
Why?
|
| Antigens, Differentiation | 1 | 1996 | 912 | 0.110 |
Why?
|
| Respiration | 1 | 2020 | 1648 | 0.110 |
Why?
|
| Trinucleotide Repeats | 1 | 2014 | 257 | 0.110 |
Why?
|
| Catecholamines | 3 | 1995 | 385 | 0.110 |
Why?
|
| DNA-Binding Proteins | 4 | 2024 | 9590 | 0.110 |
Why?
|
| Ataxia | 1 | 2015 | 305 | 0.110 |
Why?
|
| Optic Nerve | 1 | 2017 | 567 | 0.110 |
Why?
|
| Axons | 3 | 2017 | 1672 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2019 | 817 | 0.110 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 1992 | 43 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1617 | 0.110 |
Why?
|
| Membrane Lipids | 1 | 2014 | 251 | 0.110 |
Why?
|
| Demyelinating Diseases | 2 | 2008 | 351 | 0.110 |
Why?
|
| Superoxides | 2 | 2005 | 387 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 3 | 2015 | 1335 | 0.100 |
Why?
|
| Chlorides | 1 | 2015 | 666 | 0.100 |
Why?
|
| Sciatic Nerve | 2 | 1995 | 612 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2021 | 1180 | 0.100 |
Why?
|
| Cystine | 4 | 2003 | 94 | 0.100 |
Why?
|
| Signal Transduction | 8 | 2020 | 23363 | 0.100 |
Why?
|
| Phosphatidylethanolamines | 1 | 1992 | 129 | 0.100 |
Why?
|
| NAD | 1 | 1996 | 610 | 0.100 |
Why?
|
| Male | 44 | 2021 | 359413 | 0.100 |
Why?
|
| Memory Disorders | 1 | 2019 | 1197 | 0.100 |
Why?
|
| Female | 37 | 2021 | 391011 | 0.100 |
Why?
|
| Calcineurin | 2 | 2004 | 229 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 1083 | 0.100 |
Why?
|
| Biological Transport, Active | 1 | 2012 | 328 | 0.100 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1992 | 224 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2012 | 5039 | 0.100 |
Why?
|
| Biological Transport | 5 | 1998 | 2087 | 0.100 |
Why?
|
| Mice, Transgenic | 5 | 2020 | 9531 | 0.100 |
Why?
|
| Tooth Root | 6 | 2011 | 162 | 0.100 |
Why?
|
| Ethylenediamines | 2 | 2017 | 57 | 0.100 |
Why?
|
| Psychomotor Agitation | 1 | 2014 | 306 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2004 | 2441 | 0.100 |
Why?
|
| Hydrolysis | 5 | 2000 | 665 | 0.100 |
Why?
|
| Biotinylation | 2 | 2011 | 184 | 0.100 |
Why?
|
| Thyroid Hormones | 1 | 2014 | 403 | 0.090 |
Why?
|
| Phosphatidylserines | 1 | 1992 | 188 | 0.090 |
Why?
|
| Dizocilpine Maleate | 3 | 2004 | 172 | 0.090 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1991 | 67 | 0.090 |
Why?
|
| Bicuculline | 2 | 2009 | 96 | 0.090 |
Why?
|
| Citalopram | 1 | 2014 | 402 | 0.090 |
Why?
|
| Liposomes | 1 | 2015 | 776 | 0.090 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2014 | 489 | 0.090 |
Why?
|
| Caspase 3 | 4 | 2007 | 730 | 0.090 |
Why?
|
| Biopsy | 2 | 2015 | 6775 | 0.090 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2014 | 385 | 0.090 |
Why?
|
| Cell Count | 4 | 2004 | 1838 | 0.090 |
Why?
|
| Radiography, Dental, Digital | 1 | 2010 | 13 | 0.090 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 1430 | 0.090 |
Why?
|
| Transcription Factors | 4 | 2024 | 12100 | 0.090 |
Why?
|
| Dental Cementum | 1 | 2010 | 53 | 0.090 |
Why?
|
| Pulpotomy | 1 | 2009 | 4 | 0.090 |
Why?
|
| Phospholipases A2 | 4 | 1995 | 197 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2019 | 10434 | 0.090 |
Why?
|
| Evidence-Based Dentistry | 1 | 2009 | 17 | 0.090 |
Why?
|
| Disaster Planning | 1 | 2016 | 560 | 0.090 |
Why?
|
| Nitrogen Oxides | 2 | 2000 | 128 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2020 | 2255 | 0.090 |
Why?
|
| DNA Primers | 1 | 2014 | 2819 | 0.090 |
Why?
|
| Periapical Granuloma | 1 | 2009 | 2 | 0.090 |
Why?
|
| Free Radical Scavengers | 4 | 2006 | 211 | 0.080 |
Why?
|
| Glucose | 4 | 2013 | 4361 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2006 | 490 | 0.080 |
Why?
|
| Anesthesia, Spinal | 1 | 2012 | 280 | 0.080 |
Why?
|
| Root Canal Irrigants | 3 | 2015 | 15 | 0.080 |
Why?
|
| Sodium Channels | 1 | 2011 | 344 | 0.080 |
Why?
|
| Vasoconstrictor Agents | 3 | 2012 | 651 | 0.080 |
Why?
|
| Phospholipases | 3 | 1980 | 76 | 0.080 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2018 | 686 | 0.080 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 493 | 0.080 |
Why?
|
| Growth Substances | 2 | 2010 | 768 | 0.080 |
Why?
|
| Aluminum Compounds | 3 | 2015 | 54 | 0.080 |
Why?
|
| GABA Antagonists | 1 | 2009 | 120 | 0.080 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2008 | 550 | 0.080 |
Why?
|
| Calcium Compounds | 3 | 2015 | 38 | 0.080 |
Why?
|
| Membranes, Artificial | 3 | 2004 | 367 | 0.080 |
Why?
|
| Silicates | 3 | 2015 | 47 | 0.080 |
Why?
|
| Fear | 1 | 2018 | 1462 | 0.080 |
Why?
|
| Gramicidin | 2 | 1978 | 12 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2006 | 613 | 0.080 |
Why?
|
| Nerve Block | 3 | 2012 | 686 | 0.080 |
Why?
|
| Tritium | 1 | 2009 | 707 | 0.080 |
Why?
|
| Pyridines | 2 | 2018 | 2877 | 0.080 |
Why?
|
| Photoplethysmography | 1 | 2009 | 60 | 0.080 |
Why?
|
| Cytoprotection | 1 | 2009 | 200 | 0.080 |
Why?
|
| Brain Chemistry | 3 | 2004 | 959 | 0.080 |
Why?
|
| Alveolar Process | 1 | 2010 | 294 | 0.080 |
Why?
|
| Gangliosides | 1 | 2009 | 132 | 0.080 |
Why?
|
| Potassium | 3 | 2013 | 1318 | 0.080 |
Why?
|
| Gingival Overgrowth | 1 | 2008 | 7 | 0.080 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 2 | 2006 | 20 | 0.080 |
Why?
|
| Stroke | 2 | 2019 | 9945 | 0.080 |
Why?
|
| Phenotype | 4 | 2018 | 16543 | 0.080 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 3 | 2003 | 70 | 0.080 |
Why?
|
| Protein Transport | 2 | 2004 | 1966 | 0.080 |
Why?
|
| Cysteine | 3 | 2004 | 897 | 0.080 |
Why?
|
| Sodium Channel Blockers | 1 | 2009 | 172 | 0.080 |
Why?
|
| Smear Layer | 1 | 2007 | 4 | 0.080 |
Why?
|
| Testicular Neoplasms | 1 | 2014 | 800 | 0.080 |
Why?
|
| Inflammation Mediators | 2 | 2008 | 1882 | 0.080 |
Why?
|
| Ionophores | 2 | 2006 | 107 | 0.080 |
Why?
|
| Chemokine CXCL12 | 1 | 2010 | 454 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2014 | 1576 | 0.070 |
Why?
|
| Immunity, Innate | 4 | 2011 | 3046 | 0.070 |
Why?
|
| Glutamine | 1 | 1991 | 576 | 0.070 |
Why?
|
| Marine Toxins | 1 | 2007 | 24 | 0.070 |
Why?
|
| Carbocyanines | 2 | 2006 | 174 | 0.070 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2007 | 18 | 0.070 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2008 | 84 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 4172 | 0.070 |
Why?
|
| Caspases | 3 | 2006 | 878 | 0.070 |
Why?
|
| Sleep Stages | 2 | 2006 | 685 | 0.070 |
Why?
|
| Time Factors | 12 | 2010 | 40133 | 0.070 |
Why?
|
| Muscle Contraction | 4 | 2005 | 1201 | 0.070 |
Why?
|
| Oxides | 3 | 2015 | 400 | 0.070 |
Why?
|
| Anesthetics, Combined | 1 | 2007 | 42 | 0.070 |
Why?
|
| Diagonal Band of Broca | 1 | 2006 | 5 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 2 | 2012 | 1483 | 0.070 |
Why?
|
| Maleimides | 1 | 2007 | 114 | 0.070 |
Why?
|
| Population Surveillance | 2 | 2016 | 2609 | 0.070 |
Why?
|
| Pathology | 1 | 2010 | 270 | 0.070 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 282 | 0.070 |
Why?
|
| Oxadiazoles | 1 | 2006 | 94 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 819 | 0.070 |
Why?
|
| Gingiva | 3 | 2004 | 406 | 0.070 |
Why?
|
| Xanthines | 1 | 2006 | 122 | 0.070 |
Why?
|
| Coculture Techniques | 2 | 2008 | 1340 | 0.070 |
Why?
|
| Base Sequence | 4 | 2014 | 12447 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2014 | 6067 | 0.070 |
Why?
|
| Sarcolemma | 2 | 2011 | 65 | 0.070 |
Why?
|
| Remission, Spontaneous | 1 | 2007 | 383 | 0.070 |
Why?
|
| Dental Pulp Devitalization | 1 | 2006 | 1 | 0.070 |
Why?
|
| Composite Resins | 2 | 2011 | 68 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 1920 | 0.070 |
Why?
|
| Dogs | 2 | 2015 | 3843 | 0.070 |
Why?
|
| Brain Damage, Chronic | 1 | 2007 | 267 | 0.070 |
Why?
|
| Naphthalenes | 1 | 2007 | 198 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2014 | 18134 | 0.070 |
Why?
|
| Neurogenesis | 1 | 2012 | 855 | 0.070 |
Why?
|
| Granulation Tissue | 1 | 2006 | 92 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2006 | 174 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2014 | 2777 | 0.070 |
Why?
|
| Dendrites | 2 | 2002 | 475 | 0.070 |
Why?
|
| Case-Control Studies | 4 | 2013 | 22041 | 0.070 |
Why?
|
| Ependyma | 1 | 2005 | 55 | 0.070 |
Why?
|
| Behavior, Animal | 2 | 2013 | 1861 | 0.060 |
Why?
|
| Retina | 1 | 2017 | 2635 | 0.060 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 907 | 0.060 |
Why?
|
| Phosphoric Acids | 2 | 1979 | 20 | 0.060 |
Why?
|
| Dentin | 3 | 2012 | 74 | 0.060 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2005 | 89 | 0.060 |
Why?
|
| Bone Cements | 2 | 2004 | 324 | 0.060 |
Why?
|
| Regional Blood Flow | 1 | 2009 | 1490 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2007 | 1746 | 0.060 |
Why?
|
| Pain Measurement | 3 | 2012 | 3514 | 0.060 |
Why?
|
| Veratridine | 2 | 1996 | 24 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 877 | 0.060 |
Why?
|
| Cell Culture Techniques | 2 | 2003 | 1663 | 0.060 |
Why?
|
| Pipecolic Acids | 3 | 2000 | 78 | 0.060 |
Why?
|
| Positron-Emission Tomography | 2 | 2013 | 6457 | 0.060 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2005 | 543 | 0.060 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2006 | 369 | 0.060 |
Why?
|
| Alanine | 1 | 2008 | 607 | 0.060 |
Why?
|
| Brain Mapping | 2 | 2020 | 6562 | 0.060 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2004 | 69 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1995 | 2874 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 514 | 0.060 |
Why?
|
| Brain Diseases | 1 | 1994 | 1540 | 0.060 |
Why?
|
| Receptors, Muscarinic | 1 | 2005 | 157 | 0.060 |
Why?
|
| Physical Exertion | 2 | 2005 | 662 | 0.060 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2004 | 51 | 0.060 |
Why?
|
| Isoproterenol | 2 | 1995 | 394 | 0.060 |
Why?
|
| Physical Conditioning, Animal | 2 | 2006 | 366 | 0.060 |
Why?
|
| Root Canal Obturation | 3 | 2005 | 9 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 796 | 0.060 |
Why?
|
| Anesthesia, Local | 2 | 1985 | 276 | 0.060 |
Why?
|
| Middle Aged | 15 | 2021 | 220175 | 0.060 |
Why?
|
| Dental Restoration Failure | 1 | 2005 | 154 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 1995 | 2218 | 0.060 |
Why?
|
| Drug Combinations | 4 | 2015 | 2024 | 0.060 |
Why?
|
| Transfection | 4 | 2011 | 5782 | 0.060 |
Why?
|
| Body Weight | 1 | 2015 | 4613 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2004 | 189 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 435 | 0.060 |
Why?
|
| Electroencephalography | 3 | 2015 | 6182 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2019 | 3202 | 0.060 |
Why?
|
| Telencephalon | 1 | 2004 | 142 | 0.060 |
Why?
|
| TRPC Cation Channels | 1 | 2004 | 110 | 0.060 |
Why?
|
| Peroxides | 1 | 2004 | 73 | 0.060 |
Why?
|
| gamma-Glutamylcyclotransferase | 1 | 2003 | 8 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2019 | 6540 | 0.060 |
Why?
|
| Observer Variation | 1 | 2010 | 2596 | 0.060 |
Why?
|
| Sodium Hypochlorite | 2 | 2015 | 31 | 0.060 |
Why?
|
| Infant | 6 | 2019 | 36030 | 0.060 |
Why?
|
| Rats, Inbred Strains | 4 | 1994 | 2094 | 0.060 |
Why?
|
| Intracellular Fluid | 2 | 2000 | 201 | 0.060 |
Why?
|
| Locus Coeruleus | 1 | 1985 | 231 | 0.060 |
Why?
|
| Oxidants | 1 | 2004 | 169 | 0.050 |
Why?
|
| Stereoisomerism | 2 | 1996 | 618 | 0.050 |
Why?
|
| Aldehydes | 1 | 2004 | 171 | 0.050 |
Why?
|
| Receptors, Kainic Acid | 1 | 2003 | 90 | 0.050 |
Why?
|
| Office Visits | 1 | 2007 | 597 | 0.050 |
Why?
|
| Phospholipids | 3 | 1990 | 789 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2009 | 1132 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2013 | 8553 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2014 | 2093 | 0.050 |
Why?
|
| Antibody Specificity | 2 | 2004 | 1061 | 0.050 |
Why?
|
| Bystander Effect | 1 | 2003 | 90 | 0.050 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2003 | 76 | 0.050 |
Why?
|
| Muscle Proteins | 2 | 2004 | 1152 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 3800 | 0.050 |
Why?
|
| Sleep Deprivation | 2 | 2006 | 840 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 11902 | 0.050 |
Why?
|
| Cerebral Palsy | 2 | 2004 | 471 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 1346 | 0.050 |
Why?
|
| Hotlines | 1 | 2002 | 55 | 0.050 |
Why?
|
| Heart Rate | 1 | 2014 | 4169 | 0.050 |
Why?
|
| Dental Alloys | 2 | 2000 | 29 | 0.050 |
Why?
|
| Benzimidazoles | 2 | 2006 | 858 | 0.050 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 7016 | 0.050 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2004 | 196 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2007 | 2056 | 0.050 |
Why?
|
| Bucladesine | 1 | 2002 | 118 | 0.050 |
Why?
|
| Fructose | 1 | 2004 | 287 | 0.050 |
Why?
|
| Anthrax | 1 | 2002 | 88 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2004 | 345 | 0.050 |
Why?
|
| Down-Regulation | 3 | 2006 | 2918 | 0.050 |
Why?
|
| DNA, Complementary | 3 | 2005 | 1993 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2008 | 1344 | 0.050 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2002 | 317 | 0.050 |
Why?
|
| Pregnancy | 7 | 2009 | 29725 | 0.050 |
Why?
|
| Seizures | 2 | 2013 | 2916 | 0.050 |
Why?
|
| Models, Biological | 7 | 2019 | 9468 | 0.050 |
Why?
|
| Rhombencephalon | 1 | 2001 | 81 | 0.050 |
Why?
|
| Dental Occlusion | 1 | 1981 | 53 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 835 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2009 | 2202 | 0.050 |
Why?
|
| Bronchi | 1 | 2005 | 848 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2002 | 1792 | 0.050 |
Why?
|
| Double-Blind Method | 3 | 2014 | 12412 | 0.050 |
Why?
|
| Patient Care Planning | 2 | 2014 | 909 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 854 | 0.050 |
Why?
|
| Phencyclidine | 1 | 2000 | 60 | 0.050 |
Why?
|
| Caffeine | 1 | 2005 | 701 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2005 | 5784 | 0.050 |
Why?
|
| Equipment Design | 1 | 2009 | 3520 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 1994 | 3127 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 2651 | 0.050 |
Why?
|
| Osmolar Concentration | 2 | 1994 | 662 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2003 | 523 | 0.040 |
Why?
|
| Spinal Cord | 3 | 2003 | 1817 | 0.040 |
Why?
|
| Neuropeptides | 2 | 1996 | 941 | 0.040 |
Why?
|
| Muscles | 2 | 1988 | 1581 | 0.040 |
Why?
|
| Proteins | 1 | 1995 | 6030 | 0.040 |
Why?
|
| Resin Cements | 1 | 2000 | 31 | 0.040 |
Why?
|
| Cell Division | 4 | 2004 | 4462 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 1174 | 0.040 |
Why?
|
| Anticonvulsants | 2 | 2008 | 1881 | 0.040 |
Why?
|
| S-Nitrosoglutathione | 1 | 1999 | 23 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 2001 | 1544 | 0.040 |
Why?
|
| Xanthenes | 1 | 1999 | 72 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 36247 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2005 | 2909 | 0.040 |
Why?
|
| Collagen | 3 | 2012 | 2635 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2004 | 963 | 0.040 |
Why?
|
| Acid Etching, Dental | 1 | 1979 | 40 | 0.040 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 1634 | 0.040 |
Why?
|
| Memory, Long-Term | 1 | 2019 | 58 | 0.040 |
Why?
|
| Type C Phospholipases | 1 | 1980 | 287 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2013 | 64947 | 0.040 |
Why?
|
| Gene Library | 1 | 2002 | 1060 | 0.040 |
Why?
|
| Lipid Peroxidation | 2 | 2014 | 271 | 0.040 |
Why?
|
| Dental Bonding | 1 | 1979 | 35 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2011 | 3811 | 0.040 |
Why?
|
| Homozygote | 1 | 2004 | 1786 | 0.040 |
Why?
|
| Purine Nucleosides | 1 | 1998 | 30 | 0.040 |
Why?
|
| Kynurenine | 1 | 2019 | 140 | 0.040 |
Why?
|
| Calcium Radioisotopes | 1 | 1998 | 9 | 0.040 |
Why?
|
| Purine Nucleotides | 1 | 1998 | 27 | 0.040 |
Why?
|
| Indoles | 1 | 2007 | 1830 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2005 | 1434 | 0.040 |
Why?
|
| Nerve Degeneration | 1 | 2003 | 748 | 0.040 |
Why?
|
| Mutagens | 1 | 1999 | 178 | 0.040 |
Why?
|
| Insulin | 1 | 2013 | 6592 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2007 | 1428 | 0.040 |
Why?
|
| Guanylate Cyclase | 1 | 1999 | 205 | 0.040 |
Why?
|
| Hypercapnia | 1 | 2020 | 261 | 0.040 |
Why?
|
| Aged | 10 | 2021 | 168995 | 0.040 |
Why?
|
| Microinjections | 3 | 2006 | 321 | 0.040 |
Why?
|
| Dental Amalgam | 2 | 1996 | 65 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2001 | 1955 | 0.040 |
Why?
|
| Alkylation | 1 | 1998 | 84 | 0.040 |
Why?
|
| Odontometry | 2 | 1980 | 29 | 0.040 |
Why?
|
| 2-Aminoadipic Acid | 1 | 1998 | 33 | 0.040 |
Why?
|
| Sudden Infant Death | 1 | 2000 | 291 | 0.040 |
Why?
|
| Sleep | 2 | 2006 | 4746 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 3 | 1992 | 412 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1998 | 489 | 0.040 |
Why?
|
| Odontoblasts | 2 | 2012 | 14 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2004 | 1617 | 0.040 |
Why?
|
| Reperfusion Injury | 1 | 2004 | 1023 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 3086 | 0.040 |
Why?
|
| Coenzymes | 2 | 1994 | 102 | 0.040 |
Why?
|
| Sulfanilic Acids | 1 | 2017 | 13 | 0.040 |
Why?
|
| Ethylamines | 1 | 2017 | 17 | 0.040 |
Why?
|
| Oxazines | 1 | 1999 | 341 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2010 | 20048 | 0.040 |
Why?
|
| Pedigree | 2 | 2015 | 4577 | 0.040 |
Why?
|
| Heterozygote | 1 | 2004 | 2797 | 0.040 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 1996 | 38 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2019 | 42034 | 0.040 |
Why?
|
| Ultrasonic Therapy | 2 | 1997 | 215 | 0.030 |
Why?
|
| Sea Urchins | 1 | 1996 | 45 | 0.030 |
Why?
|
| Tooth Fractures | 2 | 2012 | 28 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2002 | 1091 | 0.030 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2006 | 1300 | 0.030 |
Why?
|
| Histocytochemistry | 2 | 1989 | 693 | 0.030 |
Why?
|
| Medical Errors | 1 | 2005 | 1255 | 0.030 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 1996 | 56 | 0.030 |
Why?
|
| Post and Core Technique | 1 | 1996 | 18 | 0.030 |
Why?
|
| Adult | 13 | 2020 | 219847 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 670 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2018 | 266 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2006 | 2982 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 2 | 1997 | 833 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 1230 | 0.030 |
Why?
|
| Radiology | 1 | 2010 | 2103 | 0.030 |
Why?
|
| Autoradiography | 2 | 1995 | 730 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2004 | 1758 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2004 | 1811 | 0.030 |
Why?
|
| Dental High-Speed Equipment | 1 | 1995 | 2 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 14656 | 0.030 |
Why?
|
| Government Agencies | 1 | 2016 | 161 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 3696 | 0.030 |
Why?
|
| GAP-43 Protein | 1 | 1995 | 152 | 0.030 |
Why?
|
| Brain Stem | 1 | 2000 | 857 | 0.030 |
Why?
|
| Pain, Postoperative | 2 | 2012 | 1718 | 0.030 |
Why?
|
| Water | 2 | 1978 | 1402 | 0.030 |
Why?
|
| Retrograde Obturation | 1 | 1994 | 16 | 0.030 |
Why?
|
| Epoxy Resins | 1 | 1994 | 12 | 0.030 |
Why?
|
| Electric Conductivity | 3 | 1994 | 409 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2005 | 2861 | 0.030 |
Why?
|
| Zinc Oxide-Eugenol Cement | 1 | 2014 | 9 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 58947 | 0.030 |
Why?
|
| Neural Inhibition | 1 | 2019 | 589 | 0.030 |
Why?
|
| Breast | 1 | 2004 | 1980 | 0.030 |
Why?
|
| Methylmethacrylates | 1 | 2014 | 67 | 0.030 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 1995 | 108 | 0.030 |
Why?
|
| Cephalometry | 1 | 1976 | 382 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1995 | 178 | 0.030 |
Why?
|
| Edetic Acid | 2 | 1990 | 281 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2002 | 1334 | 0.030 |
Why?
|
| Apyrase | 1 | 1997 | 373 | 0.030 |
Why?
|
| Gels | 1 | 1995 | 419 | 0.030 |
Why?
|
| Energy Metabolism | 2 | 2021 | 2869 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 1998 | 3466 | 0.030 |
Why?
|
| Probenecid | 1 | 1994 | 75 | 0.030 |
Why?
|
| Chickens | 3 | 1991 | 859 | 0.030 |
Why?
|
| Adenine Nucleotides | 1 | 1994 | 111 | 0.030 |
Why?
|
| Motor Activity | 1 | 2004 | 2687 | 0.030 |
Why?
|
| Dental Prosthesis Design | 1 | 1996 | 263 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2010 | 4786 | 0.030 |
Why?
|
| Heredity | 1 | 2014 | 148 | 0.030 |
Why?
|
| Myogenic Regulatory Factors | 2 | 2006 | 104 | 0.030 |
Why?
|
| Serine | 1 | 1998 | 831 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 1995 | 292 | 0.030 |
Why?
|
| Nervous System Diseases | 2 | 1998 | 1647 | 0.030 |
Why?
|
| Age Factors | 2 | 2008 | 18415 | 0.030 |
Why?
|
| Spider Venoms | 1 | 2013 | 43 | 0.030 |
Why?
|
| Magnesium | 1 | 1997 | 810 | 0.030 |
Why?
|
| Androgen-Binding Protein | 1 | 1993 | 10 | 0.030 |
Why?
|
| Biological Assay | 1 | 1996 | 630 | 0.030 |
Why?
|
| Minocycline | 1 | 2014 | 168 | 0.030 |
Why?
|
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 1992 | 15 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1999 | 1521 | 0.030 |
Why?
|
| Ethers, Cyclic | 1 | 1992 | 33 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 1976 | 623 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2018 | 1518 | 0.030 |
Why?
|
| Okadaic Acid | 1 | 1992 | 67 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2002 | 17628 | 0.030 |
Why?
|
| Synaptic Membranes | 1 | 1993 | 89 | 0.030 |
Why?
|
| Metronidazole | 1 | 2014 | 231 | 0.030 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1992 | 100 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 1143 | 0.030 |
Why?
|
| Atmospheric Pressure | 1 | 2012 | 46 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 977 | 0.030 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 1992 | 64 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 1992 | 214 | 0.030 |
Why?
|
| Oocytes | 1 | 1998 | 1165 | 0.030 |
Why?
|
| Ephedrine | 1 | 2012 | 52 | 0.030 |
Why?
|
| Isomerism | 1 | 1992 | 197 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 1699 | 0.030 |
Why?
|
| Dithiothreitol | 1 | 1992 | 95 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 2014 | 312 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 1840 | 0.030 |
Why?
|
| Tooth Crown | 1 | 2012 | 61 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2825 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 1998 | 805 | 0.030 |
Why?
|
| Potassium Chloride | 1 | 1992 | 233 | 0.030 |
Why?
|
| Glycine | 2 | 2000 | 663 | 0.030 |
Why?
|
| Relaxation Therapy | 1 | 1993 | 179 | 0.030 |
Why?
|
| Dentin, Secondary | 1 | 2011 | 2 | 0.030 |
Why?
|
| Dental Pulp Calcification | 1 | 2011 | 2 | 0.030 |
Why?
|
| Indomethacin | 1 | 1992 | 326 | 0.030 |
Why?
|
| Ion Transport | 1 | 2013 | 318 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 1992 | 866 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2010 | 4735 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 724 | 0.020 |
Why?
|
| Binding Sites | 2 | 1998 | 6050 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 2012 | 316 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 1993 | 241 | 0.020 |
Why?
|
| Dental Instruments | 2 | 2005 | 17 | 0.020 |
Why?
|
| Odontogenesis | 1 | 2011 | 65 | 0.020 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2011 | 31 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 4494 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 1997 | 6242 | 0.020 |
Why?
|
| Dental Restoration, Permanent | 1 | 2011 | 128 | 0.020 |
Why?
|
| Mast Cells | 1 | 1978 | 1428 | 0.020 |
Why?
|
| Lactic Acid | 2 | 2006 | 1132 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2017 | 1036 | 0.020 |
Why?
|
| Snake Venoms | 1 | 1990 | 40 | 0.020 |
Why?
|
| Crowns | 1 | 1971 | 155 | 0.020 |
Why?
|
| Young Adult | 4 | 2020 | 58673 | 0.020 |
Why?
|
| Neurites | 1 | 1993 | 389 | 0.020 |
Why?
|
| Sensation | 1 | 2012 | 331 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 4 | 1997 | 1628 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2014 | 625 | 0.020 |
Why?
|
| tau Proteins | 1 | 2021 | 2095 | 0.020 |
Why?
|
| Cresols | 1 | 1970 | 26 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2012 | 416 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2019 | 13456 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1976 | 1132 | 0.020 |
Why?
|
| Smell | 1 | 1972 | 259 | 0.020 |
Why?
|
| Hernia, Inguinal | 1 | 2012 | 220 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4264 | 0.020 |
Why?
|
| Maternal Behavior | 1 | 1972 | 306 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 25928 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1993 | 2558 | 0.020 |
Why?
|
| Cerebral Infarction | 1 | 1994 | 982 | 0.020 |
Why?
|
| Fentanyl | 1 | 2012 | 433 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2010 | 433 | 0.020 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1989 | 174 | 0.020 |
Why?
|
| Gene Expression | 2 | 2004 | 7592 | 0.020 |
Why?
|
| Sample Size | 1 | 2012 | 840 | 0.020 |
Why?
|
| Public Health | 1 | 2002 | 2655 | 0.020 |
Why?
|
| Biological Specimen Banks | 1 | 2014 | 776 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 1972 | 453 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2021 | 5120 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2014 | 1156 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2014 | 39254 | 0.020 |
Why?
|
| Receptors, Adrenergic | 1 | 1988 | 155 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2012 | 1616 | 0.020 |
Why?
|
| Hearing | 1 | 1972 | 501 | 0.020 |
Why?
|
| Dithionitrobenzoic Acid | 2 | 2000 | 20 | 0.020 |
Why?
|
| Choline | 1 | 2010 | 513 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 1993 | 869 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 3839 | 0.020 |
Why?
|
| Valine | 1 | 1989 | 409 | 0.020 |
Why?
|
| Arousal | 1 | 1993 | 1157 | 0.020 |
Why?
|
| Creatine | 1 | 2010 | 426 | 0.020 |
Why?
|
| Laser Therapy | 1 | 1994 | 1089 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 1992 | 1021 | 0.020 |
Why?
|
| Aging | 4 | 2019 | 8641 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 4573 | 0.020 |
Why?
|
| Sensory Receptor Cells | 1 | 1972 | 509 | 0.020 |
Why?
|
| Eye | 1 | 1991 | 710 | 0.020 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2013 | 927 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 2010 | 552 | 0.020 |
Why?
|
| Imines | 1 | 2006 | 34 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2368 | 0.020 |
Why?
|
| Microdialysis | 1 | 2006 | 160 | 0.020 |
Why?
|
| Iron | 1 | 1995 | 1786 | 0.020 |
Why?
|
| Estrogen Receptor beta | 1 | 2007 | 168 | 0.020 |
Why?
|
| Cobalt | 1 | 2006 | 155 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 2563 | 0.020 |
Why?
|
| Models, Structural | 2 | 1997 | 341 | 0.020 |
Why?
|
| Ryanodine | 1 | 2005 | 46 | 0.020 |
Why?
|
| Dantrolene | 1 | 2005 | 26 | 0.020 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2005 | 20 | 0.020 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2005 | 45 | 0.020 |
Why?
|
| Cholinergic Agonists | 1 | 2005 | 75 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 815 | 0.020 |
Why?
|
| Muscle, Smooth | 2 | 2005 | 924 | 0.020 |
Why?
|
| Protein Binding | 2 | 2011 | 9336 | 0.020 |
Why?
|
| Carbachol | 1 | 2005 | 223 | 0.020 |
Why?
|
| Pressure | 2 | 2001 | 1155 | 0.020 |
Why?
|
| Corpus Callosum | 2 | 2007 | 749 | 0.020 |
Why?
|
| Electron Transport Complex IV | 1 | 2005 | 190 | 0.020 |
Why?
|
| Radiometry | 1 | 2010 | 813 | 0.010 |
Why?
|
| Silver | 2 | 1996 | 120 | 0.010 |
Why?
|
| Organ Size | 1 | 2010 | 2249 | 0.010 |
Why?
|
| Muscle Relaxants, Central | 1 | 2005 | 92 | 0.010 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 2004 | 40 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1990 | 1031 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 1992 | 1462 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 2006 | 402 | 0.010 |
Why?
|
| CHO Cells | 1 | 2007 | 1389 | 0.010 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 1993 | 1076 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2006 | 409 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2004 | 186 | 0.010 |
Why?
|
| Guided Tissue Regeneration | 1 | 2004 | 88 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2007 | 1694 | 0.010 |
Why?
|
| Buffers | 2 | 1993 | 144 | 0.010 |
Why?
|
| Erythroid Precursor Cells | 1 | 2004 | 211 | 0.010 |
Why?
|
| Reactive Nitrogen Species | 1 | 2003 | 35 | 0.010 |
Why?
|
| Cricetinae | 1 | 2007 | 2427 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2010 | 1422 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2007 | 580 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 2004 | 274 | 0.010 |
Why?
|
| Arginine | 1 | 2006 | 934 | 0.010 |
Why?
|
| RNA Interference | 1 | 2011 | 2846 | 0.010 |
Why?
|
| Child | 4 | 2015 | 79758 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1988 | 1256 | 0.010 |
Why?
|
| Titanium | 2 | 1996 | 484 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2012 | 4169 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 915 | 0.010 |
Why?
|
| Tooth Abrasion | 1 | 1981 | 3 | 0.010 |
Why?
|
| Dental Occlusion, Traumatic | 1 | 1981 | 3 | 0.010 |
Why?
|
| Bruxism | 1 | 1981 | 14 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 2004 | 959 | 0.010 |
Why?
|
| Adolescent | 6 | 2015 | 87747 | 0.010 |
Why?
|
| Myoglobin | 1 | 2001 | 159 | 0.010 |
Why?
|
| Irritants | 1 | 1981 | 43 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2014 | 3530 | 0.010 |
Why?
|
| Electromyography | 1 | 2006 | 1386 | 0.010 |
Why?
|
| Receptors, Phencyclidine | 1 | 2000 | 13 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2003 | 981 | 0.010 |
Why?
|
| Limbic System | 1 | 1983 | 419 | 0.010 |
Why?
|
| Peptides | 1 | 2013 | 4358 | 0.010 |
Why?
|
| Receptors, Glycine | 1 | 2000 | 33 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 815 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2001 | 575 | 0.010 |
Why?
|
| Sulfhydryl Reagents | 1 | 2000 | 32 | 0.010 |
Why?
|
| Phosphines | 1 | 2000 | 18 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2004 | 801 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 413 | 0.010 |
Why?
|
| Rana pipiens | 1 | 1980 | 64 | 0.010 |
Why?
|
| Pentylenetetrazole | 1 | 2000 | 71 | 0.010 |
Why?
|
| Movement Disorders | 1 | 2004 | 459 | 0.010 |
Why?
|
| Anura | 1 | 1980 | 80 | 0.010 |
Why?
|
| Convulsants | 1 | 2000 | 70 | 0.010 |
Why?
|
| Nephropidae | 1 | 1980 | 70 | 0.010 |
Why?
|
| Ice | 1 | 2001 | 102 | 0.010 |
Why?
|
| Dopamine Antagonists | 1 | 2000 | 288 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2002 | 513 | 0.010 |
Why?
|
| Chemotactic Factors | 1 | 2000 | 196 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 3764 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 7593 | 0.010 |
Why?
|
| Wakefulness | 1 | 2006 | 1253 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2000 | 461 | 0.010 |
Why?
|
| Thioguanine | 1 | 1998 | 44 | 0.010 |
Why?
|
| Haloperidol | 1 | 2000 | 389 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 1972 | 0.010 |
Why?
|
| Goldfish | 1 | 1998 | 65 | 0.010 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 1998 | 45 | 0.010 |
Why?
|
| Buthionine Sulfoximine | 1 | 1998 | 17 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2001 | 778 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 1760 | 0.010 |
Why?
|
| Lipids | 1 | 1970 | 3336 | 0.010 |
Why?
|
| Osmosis | 1 | 1978 | 103 | 0.010 |
Why?
|
| Fibrosis | 1 | 2006 | 2042 | 0.010 |
Why?
|
| Research Design | 1 | 2014 | 6181 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2002 | 590 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2002 | 580 | 0.010 |
Why?
|
| Vacuoles | 1 | 1979 | 229 | 0.010 |
Why?
|
| Long-Term Potentiation | 1 | 2000 | 293 | 0.010 |
Why?
|
| Emergencies | 1 | 1985 | 1217 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1980 | 1314 | 0.010 |
Why?
|
| Inosine | 1 | 1998 | 130 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1531 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 1985 | 753 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2001 | 780 | 0.010 |
Why?
|
| Mathematics | 1 | 1978 | 708 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1999 | 561 | 0.010 |
Why?
|
| Nucleotidases | 1 | 1976 | 29 | 0.010 |
Why?
|
| Histamine | 1 | 1978 | 499 | 0.010 |
Why?
|
| Anions | 1 | 1996 | 137 | 0.010 |
Why?
|
| Radiography, Dental | 1 | 1976 | 54 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 1976 | 72 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1997 | 530 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 2005 | 1402 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 2277 | 0.010 |
Why?
|
| Dental Cavity Preparation | 1 | 1996 | 13 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 3762 | 0.010 |
Why?
|
| Fumarate Hydratase | 1 | 1976 | 52 | 0.010 |
Why?
|
| Acetylcholinesterase | 1 | 1976 | 156 | 0.010 |
Why?
|
| Stainless Steel | 1 | 1996 | 79 | 0.010 |
Why?
|
| Dental Stress Analysis | 1 | 1996 | 64 | 0.010 |
Why?
|
| Cementation | 1 | 1996 | 92 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1978 | 575 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 7400 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1979 | 863 | 0.010 |
Why?
|
| DNA | 2 | 2004 | 7236 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2001 | 1078 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1996 | 389 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2001 | 1735 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 3683 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 1755 | 0.010 |
Why?
|
| Methenamine | 1 | 1994 | 5 | 0.010 |
Why?
|
| Gestational Age | 1 | 2004 | 3564 | 0.010 |
Why?
|
| Bismuth | 1 | 1994 | 28 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1995 | 317 | 0.010 |
Why?
|
| Solubility | 1 | 1976 | 1088 | 0.010 |
Why?
|
| Diffusion | 1 | 1996 | 814 | 0.010 |
Why?
|
| Ethylmaleimide | 1 | 1994 | 70 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2008 | 6210 | 0.010 |
Why?
|
| Streptococcus | 1 | 1994 | 198 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2001 | 2363 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2001 | 1435 | 0.010 |
Why?
|
| Culture Media | 1 | 1996 | 899 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 6226 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1978 | 1090 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 5902 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 29636 | 0.010 |
Why?
|
| Sound | 1 | 1995 | 257 | 0.010 |
Why?
|
| Saponins | 1 | 1993 | 50 | 0.010 |
Why?
|
| Myocardium | 1 | 2006 | 4688 | 0.010 |
Why?
|
| Uteroglobin | 1 | 1993 | 56 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 24086 | 0.010 |
Why?
|
| Surface Properties | 1 | 1996 | 1158 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1995 | 328 | 0.010 |
Why?
|
| Species Specificity | 2 | 1983 | 2413 | 0.010 |
Why?
|
| Solutions | 1 | 1993 | 423 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 17766 | 0.010 |
Why?
|
| United States | 2 | 2016 | 72363 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1975 | 596 | 0.010 |
Why?
|
| Sense Organs | 1 | 1972 | 21 | 0.010 |
Why?
|
| Gold Alloys | 1 | 1971 | 6 | 0.010 |
Why?
|
| Materials Testing | 1 | 1996 | 858 | 0.010 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 1993 | 88 | 0.010 |
Why?
|
| Housing, Animal | 1 | 1972 | 47 | 0.010 |
Why?
|
| Needles | 1 | 1995 | 451 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1995 | 655 | 0.010 |
Why?
|
| Pregnancy, Animal | 1 | 1972 | 124 | 0.010 |
Why?
|
| RNA | 1 | 2001 | 2721 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1997 | 2852 | 0.010 |
Why?
|
| Dental Impression Technique | 1 | 1971 | 59 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1993 | 575 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1996 | 1666 | 0.010 |
Why?
|
| Tyrosine | 1 | 1995 | 1440 | 0.010 |
Why?
|
| Proadifen | 1 | 1970 | 11 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 1976 | 1188 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 1996 | 1206 | 0.010 |
Why?
|
| Maxilla | 1 | 1973 | 490 | 0.010 |
Why?
|
| Venoms | 1 | 1970 | 96 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1995 | 734 | 0.010 |
Why?
|
| Temperature | 1 | 1996 | 2221 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1998 | 2866 | 0.010 |
Why?
|
| Parity | 1 | 1972 | 925 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1993 | 2509 | 0.000 |
Why?
|
| Acetylcholine | 1 | 1990 | 629 | 0.000 |
Why?
|
| Drainage | 1 | 1974 | 1161 | 0.000 |
Why?
|
| Cholinesterase Inhibitors | 1 | 1970 | 238 | 0.000 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 1988 | 88 | 0.000 |
Why?
|
| Reference Values | 1 | 1995 | 4920 | 0.000 |
Why?
|
| Risk Factors | 1 | 2014 | 74269 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1988 | 534 | 0.000 |
Why?
|
| Dystrophin | 1 | 1988 | 284 | 0.000 |
Why?
|
| Cues | 1 | 1972 | 867 | 0.000 |
Why?
|
| Databases, Factual | 1 | 2002 | 8018 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1988 | 513 | 0.000 |
Why?
|
| Phosphates | 1 | 1970 | 771 | 0.000 |
Why?
|
| Glucocorticoids | 1 | 1994 | 2143 | 0.000 |
Why?
|
| Muridae | 1 | 1983 | 56 | 0.000 |
Why?
|
| Horseradish Peroxidase | 1 | 1983 | 166 | 0.000 |
Why?
|
| Thalamic Nuclei | 1 | 1983 | 111 | 0.000 |
Why?
|
| Cesarean Section | 1 | 1972 | 1386 | 0.000 |
Why?
|
| Afferent Pathways | 1 | 1983 | 299 | 0.000 |
Why?
|
| Triglycerides | 1 | 1970 | 2476 | 0.000 |
Why?
|
| Cholesterol | 1 | 1970 | 2925 | 0.000 |
Why?
|
| Liver | 1 | 1970 | 7512 | 0.000 |
Why?
|
| Cattle | 1 | 1979 | 3847 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1973 | 15680 | 0.000 |
Why?
|
| Radiography | 1 | 1980 | 6965 | 0.000 |
Why?
|